Hey what is the Total %age Goldman Sachs HAS? 20 something now? NEWS:
From: newsout@stockwatch.com
Date: Tue, 07 Mar 2000 05:21:59 -0800
Subject: Stockwatch: Inflazyme Pharmaceuticals Ltd - News Release
Inflazyme warrants exercised
Inflazyme Pharmaceuticals Ltd IZP
Shares issued 44,379,628 Mar 6 close $6.35
Tue 7 Mar 2000 News Release
Mr. Jeffrey Bacha reports
The Goldman Sachs Group, Inc. and Biotechnology Investments Limited (BIL)
have exercised all of their Series A common share purchase warrants issued
on March 6, 1996. Accordingly, the company has issued 3,260,868 common
shares for total proceeds of $7,108,692. In addition, National Bank
Financial Inc. exercised 371,250 agents warrants (issued in connection with
the company's 1999 financing) for total proceeds to the company of
$464,062.
Ian McBeath, Inflazyme's president and chief executive officer, said,
"Inflazyme is pleased to have the continuing support of Goldman Sachs and
BIL as we move forward in our efforts to develop novel therapies for
inflammatory diseases and immunological disorders."
WARNING: The company relies on litigation protection for "forward-looking"
statements.
canada-stockwatch.com
Chuckaworm- and it ain't TOXIX. Gaarh is best served when live. ( Klingon quote. ) |
